Scotts Miracle-Gro FY2025 sales down 4% to $3.41 billion; adjusted EPS up to $3.74
Scotts Miracle-Gro reported fiscal 2025 results for the year ended September 30, 2025, with net sales down 4% to $3.41 billion from $3.55 billion. GAAP diluted EPS was $2.47, compared with a loss of $0.61 a year earlier, and adjusted EPS rose to $3.74 from $2.29. The company also gave fiscal 2026 guidance calling for adjusted EPS of $4.15 to $4.35, which matters to shareholders as a benchmark for next year's earnings.
Key points
- Fiscal 2025 net sales were $3,413.1 million, down from $3,552.7 million; fourth-quarter net sales fell 7% to $387.4 million
- GAAP diluted EPS was $2.47 for fiscal 2025 versus a loss of $0.61 in fiscal 2024; adjusted diluted EPS was $3.74 versus $2.29
- Fourth-quarter net loss narrowed to $151.8 million from $244.0 million a year earlier
- Fiscal 2026 guidance includes adjusted EPS of $4.15 to $4.35 and free cash flow of $275 million
The filing
Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.